Patent · US Active

Modified FGF-21 polypeptides and their uses

US10961291B2 · kind B2 · utility

1Cited by
184References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2019
Grant dateMar 30, 2021
Priority date—
Expiry dateJun 17, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified FGF-21 polypeptides and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.